Dr. Thomas Anthony Abbruzzese, MD

Dr. Abbruzzese practices at HCA Florida Brandon Hospital in Brandon, Florida, part of HCA Healthcare.

Dr. Abbruzzese's NPI, 1689710279, was assigned on January 30, 2007. Dr. Abbruzzese graduated from Stanford University School Of Medicine in 2000. Dr. Abbruzzese holds Florida license ME101072.

Dr. Abbruzzese's primary practice is HCA Florida Brandon Hospital, at 119 Oakfield Dr, Brandon, FL 33511 in Hillsborough County. The practice phone is (813) 916-0600.

Dr. Abbruzzese's primary practice is HCA Florida Brandon Hospital in Brandon, Florida, part of HCA Healthcare. The medical group on file is HCA Florida Heart Institute - Northside. Dmand AI also links Dr. Abbruzzese to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abbruzzese practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Abbruzzese's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Abbruzzese is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Abbruzzese's licenses on file in 6 states: Florida, Colorado, Massachusetts, Georgia, Connecticut and Utah.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization and heart device and aorta surgery among the conditions Dr. Abbruzzese treats.

CMS data shows 395 Medicare services from Dr. Abbruzzese across 9 procedure codes in 2024, for 189 Medicare patients. Medicare paid $45,247 for them.

CMS counts 189 Medicare patients who saw Dr. Abbruzzese in 2024. The largest group is 75 to 84, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abbruzzese's median patient age at 73, with 51% women.

In 2024, Dr. Abbruzzese wrote 22 Medicare Part D claims. 50% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $216 in total drug cost. In 2021, CMS named 33 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Abbruzzese for performance year 2024, reported individually. Dr. Abbruzzese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abbruzzese as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Abbruzzese, published from 2008 to 2025. 2008 was the busiest year, with 3. The most frequent topics are Regional Blood Flow, Aorta, Abdominal and Aortic Aneurysm, Abdominal. Dr. Abbruzzese has published most often in J Vasc Surg. Dr. Abbruzzese's most frequent co-authors are Ronald Lee Dalman, MD, Jeanwan Kang, MD and Virendra I. Patel, MD, MPH.

CMS Open Payments shows 62 general payments to Dr. Abbruzzese from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Endologix, Inc. paid the most, $1,118.

Dmand AI lists 1 award for Dr. Abbruzzese.

Dr. Abbruzzese graduated from Stanford University School Of Medicine in 2000. Dr. Abbruzzese is a member of ACS.

Dr. Abbruzzese is in network with 19 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.